RNAM - Avidity Biosciences Inc
0 0%
Share volume: 0
Last Updated:
Pharmaceutical Products/Pharmaceutical Preparations:
3.19%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2025 | |
|---|---|---|
| Fiscal Quarter | Q4 2025 | |
| Report Date | 02-23-2026 | |
| Assets | ||
| Total Assets | 1.958 B | |
| Current Assets | 1.798 B | |
| Inventories | 0.000 | |
| Other Current Assets | 0.000 | |
| Short Term Investments | 1.314 B | |
| Total Receivables | 0.000 | |
| Current Cash | 382.517 M | |
| Total Non-current Assets | 0.000 | |
| Property Plant Equipment | 23.333 M | |
| Other Assets | 136.250 M | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 1.958 B | |
| Total liabilities | 269.450 M | |
| Total current liabilities | 195.446 M | |
| Accounts Payable | 12.403 M | |
| Other liabilities | 45.313 M | |
| Current long term debt | 0.000 | |
| Long term debt | 0.000 | |
| Other liabilities | 45.313 M | |
| Minority interest | 0.000 | |
| Total Shareholder equity | 1.689 B | |
| Common stock | 3.264 B | |
| Retained earnings | -1.578 B |